PainSolve | Grünenthal
;

Grünenthal uses its own and third-party cookies to improve the browsing experience, offer personalized content and improve its services. We use analytics scripts which set tracking cookies. More details and information can be found in our Data Privacy Statement – please refer to this to adjust your settings for website analytics tracking (e.g. enable/disable). By closing this window you agree to our standard Terms of Use.

Confirm

Join our community

By facilitating collaboration, we aim to increase disease understanding and co-develop new solutions for patients with pain.

Updates & Features

Stay up to date with analysis on the latest research

The Neurobiology of the Placebo Effect – The 1st PainSolve Webinar

We are delighted to have had Prof. Ulrike Bingel (University Hospital Essen, Germany) host our inaugural PainSolve webinar on the 12th December 2018, titled, ‘Psychological and Neurobiological Mechanisms of Placebo and Nocebo Responses.’ Prof. Bingel presented pivotal studies that have moulded today’s understanding of the neurobiology and clinical relevance of the placebo and nocebo effects, with a focus on placebo analgesia.
... Discover more

How can the patient experience inform your research?

Chronic pain affects every aspect of patients’ lives. However, the experience of pain is unique to the individual, which is why effective treatment is challenging. This article summarises a patient-centric approach to research that harnesses patient insights to inform the development of new strategies with the potential for greater impact on the lives of those with chronic pain.
... Discover more

Diagnostic Challenges of Small Fibre Neuropathy

In this article Prof. Páll Karlsson (Aarhus University) highlights the need for a gold standard in the diagnosis of small fibre neuropathy (SFN). Prof. Karlsson focuses on the heterogeneity of SFN as a potential cause of this unmet need, by comparing different characteristics of the disease and those of similar diseases.
... Discover more

“Pain is not a symptom: It's a disease in its own right and needs to be addressed with innovative treatments. At Grünenthal, we want to join forces with you to make a genuine difference in the life of patients affected by pain”

Gabriel Baertschi

Chairman of the Corporate Executive Board,
Chief Executive Officer

Like
 
Share

Share this with:

These are external links and will open in a new window